Kijimea PRO Bifidobacterium Probiotic Bifidum MIMBb75, 4 Clinically Validated Strains, Supports Gut Barrier Function, Reduces Occasional Bloating, Diarrhea, Constipation, 30 Capsules
€23.60
Preis bei Onlinekauf
Kostenloser Versand
30 Tage kostenlose Rückgabe
Verkauft und versendet von copisteriaunio.egardata.net
Wir bemühen uns, Ihnen genaue Produktinformationen anzuzeigen. Hersteller, Lieferanten und andere stellen die hier gezeigten Angaben bereit.
€23.60
Preis bei Onlinekauf
Kostenloser Versand
30 Tage kostenlose Rückgabe
Verkauft und versendet von copisteriaunio.egardata.net
30 Tage kostenlose Rückgabe Details
Produktdetails
| Artikelnummer | 227535827 | Erscheinungsdatum | 2026/05/09 | Listenpreis | €23.60 | Modellnummer | 227535827 | ||
|---|---|---|---|---|---|---|---|---|---|
| Kategorie | |||||||||
- SUPPORTS GUT BARRIER FUNCTION*: In an 8-week clinical trial, Lactobacillus rhamnosus GG significantly reduced gut permeability compared to placebo¹.
- INTESTINAL REGULARITY & GASTROINTESTINAL HEALTH*: Kijimea PRO features the patented B. bifidum MIMBb75, shown in clinical testing² to support gastrointestinal comfort and reduce occasional bloating. In addition, it contains L. rhamnosus IMC 501 and L. paracasei IMC 502, which improve occasional constipation³, and L. rhamnosus GG, that reduces the incidence and duration of occasional diarrhea⁴.
- ENGINEERED FOR STABILITY: The Vcaps Plus technology protects moisture-sensitive probiotic strains during the journey to the gut. Each capsule sits in a double-wall aluminum chamber that shields the probiotic strains from light and moisture. No refrigeration is required.
- GMP-CERTIFIED MANUFACTURERS: Manufactured in GMP (Good Manufacturing Practice) certified facilities. Each batch is tested against 13 quality parameters by independent laboratories before release.
- FROM SCIENCE. FOR LIFE: At Kijimea, we have a clear vision: We want to make probiotics the foundation of a longer and healthier life. The relentless pursuit of this ambitious vision has enabled us to become the leading scientific probiotic brand in Europe today.
- *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. ¹Francavilla R, Miniello V, Magistà AM, De Canio A, Bucci N, Gagliardi F, Lionetti E, Castellaneta S, Polimeno L, Peccarisi L, Indrio F, Cavallo L. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics. 2010 Dec;126(6):e1445-52. doi: 10.1542/peds.2010-0467. Epub 2010 Nov 15. PMID: 21078735.
- ²Guglielmetti S, Mora D, Gschwender M, Popp K. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2011 May;33(10):1123-32. doi: 10.1111/j.1365-2036.2011.04633.x. Epub 2011 Mar 21. PMID: 21418261.
- ³Silvi S, Verdenelli MC, Cecchini C, Coman MM, Bernabei MS, Rosati J, De Leone R, Orpianesi C, Cresci A. Probiotic-enriched foods and dietary supplement containing SYNBIO positively affects bowel habits in healthy adults: an assessment using standard statistical analysis and Support Vector Machines. Int J Food Sci Nutr. 2014 Dec;65(8):994-1002. doi: 10.3109/09637486.2014.940284. Epub 2014 Jul 21. PMID: 25045832. ⁴Dronkers TMG, Ouwehand AC, Rijkers GT. Global analysis of clinical trials with probiotics. Heliyon. 2020 Jul 17;6(7):e04467. doi: 10.1016/j.heliyon.2020.e04467. PMID: 32715136; PMCID: PMC7371762.
| UPC | 864617000330 |
|---|---|
| ASIN | B0G72V1GRM |
| Brand Name | Kijimea |
| Unit Count | 30 Count |
| Manufacturer | Kijimea |
Korrektur der Produktinformationen
Wenn Sie Unvollständigkeiten oder Fehler in den Produktinformationen auf dieser Seite bemerken, nutzen Sie bitte das Korrekturformular unten.
Korrekturanfrage